Alpha-fetoprotein (AFP) is currently the only biomarker utilized for the detection and monitoring of HCC [5], but AFP testing has a sensitivity of only 39–64% for early-stage HCC [9]. The gene discussed is AFP; the disease is hepatocellular carcinoma.